Quantcast

Latest Echo Therapeutics Inc. Stories

2014-06-19 16:26:19

PHILADELPHIA, June 19, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that, based on preliminary results provided by Echo's proxy solicitor, stockholders have elected Shepard M. Goldberg as a new member of the Echo Board of Directors at the 2014 Annual Meeting of Stockholders held on Thursday, June 19, 2014. These preliminary...

2014-06-09 08:28:35

All Three Leading Independent Proxy Advisory Firms Now Recommend That Stockholders Vote FOR Echo's Board Nominees PHILADELPHIA, June 9, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that Egan-Jones Proxy Services, a leading independent proxy advisory firm, has recommended to its clients that Echo stockholders vote the WHITE...

2014-06-06 16:23:41

Both Leading Independent Proxy Advisory Firms Now Recommend That Stockholders Vote FOR Echo's Board Nominees PHILADELPHIA, June 6, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that ISS Proxy Advisory Services, a leading independent proxy advisory firm, has recommended to its clients that Echo stockholders vote the WHITE...

2014-06-05 16:28:54

PHILADELPHIA, June 5, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that Glass Lewis & Co., a leading independent proxy advisory service, has recommended to its clients that Echo stockholders vote the WHITE proxy card FOR both of the Echo Board of Directors' director nominees at Echo's Annual Meeting of Stockholders to be...

2014-06-05 08:28:23

PHILADELPHIA, June 5, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE) ("Echo"), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, is pleased to announce that its most recently completed clinical study of Symphony was selected for poster presentation at the 74(th) Scientific Sessions of the American Diabetes Association (ADA) which will be held June 13-17, 2014 in San Francisco, CA. The study...

2014-06-03 20:21:43

Letter Questions Whether Platinum Group Can be Trusted to Protect the Interests of Stockholders PHILADELPHIA, June 3, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it is mailing a letter to its stockholders urging them, in deciding how to vote at the upcoming 2014 Annual Meeting of Stockholders, to consider the past actions of...

2014-05-30 12:26:14

Urges Echo Stockholders to End the Era of Underperformance and Vote the GOLD Proxy Card NEW YORK, May 30, 2014 /PRNewswire/ -- Platinum Management (NY) LLC and certain affiliates, the largest stockholder of Echo Therapeutics, Inc., (NasdaqCM: ECTE) ("Echo" or "Company") owning approximately 20% of the common stock, announced today that it has filed an investor presentation detailing the case for change at Echo. Echo stockholders are strongly encouraged to view the investor...

2014-05-30 08:24:53

Echo Urges Stockholders to Elect Incumbent Directors and Reject Platinum Group's Slate PHILADELPHIA, May 30, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it is filing an investor presentation with the U.S. Securities and Exchange Commission (SEC) that comments on, among other things, the pending proxy contest by a dissident...

2014-05-29 16:26:21

Urges Stockholders to Reject Echo's Personal Attacks and Vote for Change by Returning Platinum's GOLD Proxy Card Today NEW YORK, May 29, 2014 /PRNewswire/ -- Platinum Management (NY) LLC and certain affiliates, the largest stockholder of Echo Therapeutics, Inc. (NasdaqCM: ECTE) ("Echo" or "The Company") owning approximately 20% of the common stock, announced today that it has mailed a letter to stockholders of Echo urging them to vote the GOLD proxy card or GOLD voting instruction form in...

2014-05-16 16:25:09

Letter Highlights Stark Difference Between Echo's Board Slate and Platinum's Board Slate PHILADELPHIA, May 16, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it has mailed a letter to stockholders. Echo's letter highlights, among other things, the stark difference between Echo's highly qualified and experienced nominee, Robert F....


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.